Page 743 - Week 03 - Tuesday, 21 March 2017

Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video


conditions. I have an article from the Sydney Morning Herald which suggested that they sometimes pay their workers as low as $4 an hour. Clearly, the animals consumed in KFC—

Members interjecting—

MADAM SPEAKER: Members, please.

Mr Hanson interjecting

MADAM SPEAKER: Mr Hanson! Ms Le Couteur, can you please sit down? Mr Hanson, I called members to order, and I called you by name a number of times. I expect you to heed the voice of the chair. Ms Le Couteur sought leave. She was granted leave, and I expect members to respect that leave that you have provided.

MS LE COUTEUR: I must admit I am shocked that it could be funny that people might be paid routinely as low as $4 an hour. I thought I might have had various reactions regarding what I was going to say, that is certainly not one of them. I do not have much more to say. I am proud to be able to table this on behalf of many people in Canberra and the surrounding areas. I commend the petition to the Assembly.

Petition—ministerial response

The following response to a petition has been lodged:

Access to cannabis medicines—petition 1-16

By Ms Fitzharris, Minister for Health, dated 20 February 2017, in response to a petition lodged by Mr Rattenbury on 13 December 2016 concerning medicinal cannabis.

The response read as follows:

I refer to the ACT Legislative Assembly Petition 1-16 sponsored by Mr Shane Rattenbury MLA regarding medical cannabis and am pleased to provide my response.

You would be aware that on 4 August 2016 I announced that the ACT government will work to establish an evidence-based Medicinal Cannabis Scheme (the scheme) in the ACT. The scheme will allow eligible patients safe and legal access to high quality medicinal cannabis products via prescription.

In addition, the government will appoint two expert advisory committees from across the spectrum of government agencies, non-government agencies, medical specialists and law enforcement to address the issues associated with the introduction of the scheme—including providing advice to government on the broader economic, legal and social issues and opportunities related to the introduction of a Medicinal Cannabis Scheme. I called for expressions of interest for the first of these, the Medicinal Cannabis Medical Advisory Panel, in December 2016 and will shortly recruit to the second committee, the Medicinal Cannabis Advisory Group.


Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video